Tirzepatide
It is a dual glucose-dependent insulinotropic polypeptide GIP and GLP-1 receptor agonist. Each SURPASS trial was designed to prov…
Wednesday, June 8, 2022
Edit
Showing posts with label Tirzepatide. Show all posts
Showing posts with label Tirzepatide. Show all posts
Subscribe to:
Posts (Atom)